Date  |
|
| Feb 24, 2021 4:01 PM |
OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share |
| Feb 23, 2021 7:31 AM |
OptimizeRx’s Angelo Campano Named to MM+M 40 Under 40 List |
| Feb 18, 2021 7:31 AM |
OptimizeRx Sets Fourth Quarter and Full Year 2020 Conference Call for Wednesday, February 24, 2021 at 4:30 p.m. ET |
| Feb 16, 2021 7:31 AM |
OptimizeRx to Present at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021 |
| Feb 09, 2021 9:10 AM |
OptimizeRx Announces Pricing of Public Offering of Common Stock |
| Feb 08, 2021 4:17 PM |
OptimizeRx Announces Proposed Public Offering of Common Stock |
| Jan 25, 2021 7:31 AM |
OptimizeRx Expects Q4 2020 Revenue up 117% to Record $16 Million, Full Year up 75% to Record $43 Million |
| Jan 21, 2021 7:31 AM |
OptimizeRx to Present at the B. Riley Securities 2021 Vision Day Virtual Conference on January 28, 2021 |
| Jan 06, 2021 7:31 AM |
OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021 |